Understanding how the lungs heal after injury
Official title: Cellular and molecular mechanisms of alveolar repair
Funded at Stanford University · NIH-11087551 · Data updated 2026-11-12
This study is looking at how lung cells heal after a serious condition called acute respiratory distress syndrome (ARDS), with the hope of finding better treatments to help patients recover faster and more effectively.
Quick facts
| Grant type | R01 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Stanford University NIH-funded |
| Lab location | 1 site (Stanford, United States) |
| Project start | August 1, 2023 |
| Project end | May 31, 2027 |
| Funding year | 2025 |
| Award (this year) | $673,485 |
| NIH project number | 5R01HL167410-03 |
| Project ID | NIH-11087551 on NIH RePORTER |
Who could benefit from this research
✓Could help
Ideal candidates for this research are adults over 21 who have experienced acute respiratory distress syndrome or similar lung injuries.
✕Less likely to help
Patients with chronic lung conditions unrelated to acute injuries may not benefit from this research.
What this research studies
This research investigates the cellular and molecular processes involved in the repair of lung tissue following acute respiratory distress syndrome (ARDS). By examining how alveolar cells respond to injury, the study aims to identify mechanisms that promote healing and those that hinder recovery. The research utilizes advanced techniques to map the regenerative responses of lung cells, particularly focusing on the behavior of alveolar epithelial cells. The ultimate goal is to develop targeted therapies that can enhance lung repair and improve patient outcomes.
Why it matters
Potential benefit: If successful, this research could lead to new treatments that significantly improve recovery from acute lung injuries.
How similar studies have gone: Previous research has shown promise in understanding lung repair mechanisms, but this approach aims to uncover novel insights that have not been extensively tested.
Where this research is happening
-
Stanford University
Stanford, United States Active
Researchers
- Principal investigator: Desai, Tushar Jasubhai — Stanford University
- Study coordinator: Desai, Tushar Jasubhai
Related research
Other NIH-funded projects on the same topics.
-
Multimodal AI to predict CAR-T patient response and guide safer, smarter cell design
A Stanford team is building AI tools that use patient and CAR-T cell data to predict how well a CAR-T therapy will work and what design changes might boost effectiveness and safety for people with cancer.
-
Community-driven model to reduce overdose deaths through smarter resource use
A Stanford-led project uses a data-driven model to help counties pick the best ways to prevent opioid and stimulant overdoses and save lives.
-
Center for Dissemination and Implementation at Stanford: Research Core
A Stanford-based program is advancing how evidence-based addiction treatments are implemented across settings to help people with substance use disorders receive better care.
-
Center for Dissemination and Implementation At Stanford (C-DIAS)
A center-based program at Stanford aims to speed people who need addiction treatments to get evidence-based care.
-
Mitochondrial structure and neuron health in Alzheimer's and ALS
This grant studies how mitochondrial cristae structure in neurons is controlled and how its disruption may contribute to diseases like Alzheimer's and ALS.
-
Pediatric EMS seizures: simpler age-based midazolam dosing
A nationwide trial at EMS agencies tests whether using fixed, age-based dosing of midazolam for seizures in children improves treatment speed and safety.
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page.